CLL-410 Adherence and Discontinuation Among Medicare Beneficiaries Initiating Venetoclax Versus BTKis for Relapsed/Refractory Chronic Lymphocytic Leukemia
Clinical Lymphoma, Myeloma and Leukemia
Authors
Scott F. Huntington, Beenish S. Manzoor, Justin T. Puckett, Sachin Kamal-Bahl, Hasan Alhasani, Arliene Ravelo, Mahesh Fuldeore, Jalpa A. Doshi